White Paper
What Analytical Techniques Should Pharma Companies Implement To Forecast COVID-19 Effects?
This white paper reviews the importance of companies conducting subnational econometric analysis on drug demand estimation and forecasting. Companies need to understand these effec ...
White Paper
Designing A Patient-Centric Commercial Strategy
This whitepaper addresses how RWE should be leveraged for informing various commercial decisions with a deeper-dive into marketing-mix analysis (MMx). ...
White Paper
Are Pharmaceutical Direct-To-Consumer TV Ads Appropriate? A Commentary
No pharmaceutical topic causes as much passionate difference of opinions between industry and medical community representatives as the practice of direct-to-consumer advertising (D ...
White Paper
Pharma Sales And Marketing Restrictions – Has the Pendulum Swung Too Far?
The question this commentary asks is simply this – has the pendulum swung too far in the direction of excessive restrictions on sales and marketing practices of biopharmaceut ...
White Paper
The Changing Role Of Pharma Sales And Marketing In A Specialty Medicine Environment
The growing shift to specialty medicines in the US pharma market is well documented. Pricing issues are becoming more common and controversial, with questions being raised about th ...
White Paper
Is Channel ROI Dead?
From broadcasting a series of monologues at ‘easy’ customers in order to sell products, to having an engaging and effective dialogue with fairly ‘complex’ targets to make m ...
